Moreover, the interaction between B cells and TNBC tumor cells, leading to an upregulation of the inflammatory cytokines IL-4 and IL-10 that drive the chronic inflammatory response of the tumor, may impede the antibody-mediated immune response (110). The gene discussed is IL4; the disease is neoplasm.